Home › Companies › Encompass Health Corporation › 2025-2026

Encompass Health Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Encompass Health Corporation’s Form 8-K, filed 2026-05-11 (Item 5.07 on EDGAR). Page generated 04 October 2026.

14Reported items
597Asset managers
8,111Fund votes
2026-05-07Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Encompass Health Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Encompass Health Corporation

These tallies are Encompass Health Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Encompass Health Corporation — official shareholder meeting results, meeting held 2026-05-07
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Greg D. Carmichael	83,864,985	2,589,495	65,761	--	--	Majority: yes
Elect Director: Edward M. Christie III	85,754,908	700,355	64,978	--	--	Majority: yes
Elect Director: Cain A. Hayes	84,565,203	1,890,393	64,645	--	--	Majority: yes
Elect Director: Joan E. Herman	84,637,706	1,813,918	68,617	--	--	Majority: yes
Elect Director: Leslye G. Katz	84,171,691	2,280,317	68,233	--	--	Majority: yes
Elect Director: Kevin J. O'Connor	84,595,415	1,858,465	66,361	--	--	Majority: yes
Elect Director: Christopher R. Reidy	84,905,561	1,549,741	64,939	--	--	Majority: yes
Elect Director: Nancy M. Schlichting	85,532,660	921,686	65,895	--	--	Majority: yes
Elect Director: Mark J. Tarr	85,902,549	552,777	64,915	--	--	Majority: yes
Elect Director: Terrance Williams	84,973,303	1,467,143	79,795	--	--	Majority: yes
• Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm, passed:	88,444,873	3,608,490	68,452	--	--	Majority: yes
• Proposal 3, approval of the compensation of the Company's named executive officers, passed:	83,410,829	3,006,776	102,636	--	--	Majority: yes

Source: Encompass Health Corporation, Form 8-K, filed with the SEC on 2026-05-11 — read the filing on EDGAR.

How asset managers voted at the Encompass Health Corporation 2025-2026 meeting

Each item below shows how the 597 asset managers that disclosed a Encompass Health Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Encompass Health Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. An advisory vote to approve executive compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 83,410,829AGAINST: 3,006,776

Encompass Health Corporation’s own tally for this item (“• Proposal 3, approval of the compensation of the Company's named executive officers, passed:”): 83,410,829 for, 3,006,776 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).

The 570 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 98%

FOR: 97.6%AGAINST: 2.3%ABSTAIN: 0.1%NOT VOTED: 0.1%

Largest asset managers voting on “An advisory vote to approve executive compensation.” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Vote
Vanguard	12,494,644	5	For
T. Rowe Price	11,327,613	0	For
BlackRock	9,666,796	2,720	For
Invesco	6,969,791	0	For
Wellington	3,249,903	0	For
State Street	2,801,093	3,419	For
AllianceBernstein	2,558,256	0	For
Fidelity	2,247,988	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	2,221,620	0	For
Capitol Series Trust	2,129,381	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,861,293	0	For
Thrivent	1,478,519	0	For
Charles Schwab	1,386,767	0	For
Two Sigma	1,249,301	0	For
Putnam	1,151,333	0	For
Goldman Sachs	1,064,216	0	For
American Century	1,063,482	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	953,588	0	For
Northern Trust	922,039	0	For
Amova Asset Management Co., Ltd.	874,083	0	For
SEI	811,555	27,292	For
Dimensional	825,593	0	For
Arlington Trust Co LLC	778,891	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	778,011	0	For
MELLON INVESTMENTS Corp	659,696	0	For

Showing the 25 largest of 570 asset managers. See all 570 in the interactive database.

2. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Cain A. Hayes

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 84,565,203AGAINST: 1,890,393

Encompass Health Corporation’s own tally for this item (“Elect Director: Cain A. Hayes”): 84,565,203 for, 1,890,393 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99% of the shares they voted on this item FOR (42,314,862 for, 635,981 against).

FOR 98%

FOR: 42,314,862 (98.5%)AGAINST: 635,981 (1.5%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Cai” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,227	4	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	551,679	18,003	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	0	491,921	0	Against
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	467,964	5,911	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

3. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Christopher R. Reidy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 84,905,561AGAINST: 1,549,741

Encompass Health Corporation’s own tally for this item (“Elect Director: Christopher R. Reidy”): 84,905,561 for, 1,549,741 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 86% for, 2% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.7% of the shares they voted on this item FOR (42,825,982 for, 124,861 against).

FOR 99.6%

FOR: 42,825,982 (99.7%)AGAINST: 124,861 (0.3%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Chr” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,228	3	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

4. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Edward M. Christie III

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 85,754,908AGAINST: 700,355

Encompass Health Corporation’s own tally for this item (“Elect Director: Edward M. Christie III”): 85,754,908 for, 700,355 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 86% for, 0.8% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.8% of the shares they voted on this item FOR (42,904,052 for, 46,791 against).

FOR 99.8%

FOR: 42,904,052 (99.8%)AGAINST: 46,791 (0.1%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Edw” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,230	1	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

5. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Greg D. Carmichael

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 83,864,985AGAINST: 2,589,495

Encompass Health Corporation’s own tally for this item (“Elect Director: Greg D. Carmichael”): 83,864,985 for, 2,589,495 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 85% for, 3% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (42,917,275 for, 33,568 against).

FOR 99.8%

FOR: 42,917,275 (99.9%)AGAINST: 33,568 (0.1%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Gre” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,706,693	5,538	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

6. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Joan E. Herman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 84,637,706AGAINST: 1,813,918

Encompass Health Corporation’s own tally for this item (“Elect Director: Joan E. Herman”): 84,637,706 for, 1,813,918 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (42,939,204 for, 11,638 against).

FOR 99.9%

FOR: 42,939,204 (99.9%)AGAINST: 11,638 (0.0%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Joa” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,706,694	5,537	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,181	42	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

7. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Kevin J. O'Connor

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 84,595,415AGAINST: 1,858,465

Encompass Health Corporation’s own tally for this item (“Elect Director: Kevin J. O'Connor”): 84,595,415 for, 1,858,465 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (42,925,213 for, 25,630 against).

FOR 99.8%

FOR: 42,925,213 (99.9%)AGAINST: 25,630 (0.1%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Kev” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,228	3	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

8. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Leslye G. Katz

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 84,171,691AGAINST: 2,280,317

Encompass Health Corporation’s own tally for this item (“Elect Director: Leslye G. Katz”): 84,171,691 for, 2,280,317 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.8% of the shares they voted on this item FOR (42,878,509 for, 72,333 against).

FOR 99.7%

FOR: 42,878,509 (99.8%)AGAINST: 72,333 (0.2%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Les” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,227	4	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,181	42	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

9. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Mark J. Tarr

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 85,902,549AGAINST: 552,777

Encompass Health Corporation’s own tally for this item (“Elect Director: Mark J. Tarr”): 85,902,549 for, 552,777 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 87% for, 0.6% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (42,949,282 for, 1,561 against).

FOR 99.9%

FOR: 42,949,282 (99.9%)AGAINST: 1,561 (0.0%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Mar” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,230	1	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

10. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Nancy M. Schlichting

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 85,532,660AGAINST: 921,686

Encompass Health Corporation’s own tally for this item (“Elect Director: Nancy M. Schlichting”): 85,532,660 for, 921,686 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 86% for, 1.0% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (42,950,842 for, 1 against).

FOR 99.9%

FOR: 42,950,842 (99.9%)AGAINST: 1 (0.0%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Nan” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,230	1	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

11. Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Terrance Williams

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 84,973,303AGAINST: 1,467,143

Encompass Health Corporation’s own tally for this item (“Elect Director: Terrance Williams”): 84,973,303 for, 1,467,143 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 86% for, 1% against (87% of the company cast a for/against vote).

The 146 asset managers below cast 99.8% of the shares they voted on this item FOR (42,883,254 for, 67,589 against).

FOR 99.7%

FOR: 42,883,254 (99.8%)AGAINST: 67,589 (0.2%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Ter” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,712,228	3	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,223	0	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

12. Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 88,444,873AGAINST: 3,608,490

Encompass Health Corporation’s own tally for this item (“• Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm, passed:”): 88,444,873 for, 3,608,490 against, per its Form 8-K filed 2026-05-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,199,080 outstanding shares: 89% for, 4% against (93% of the company cast a for/against vote).

The 145 asset managers below cast 99.9% of the shares they voted on this item FOR (42,917,359 for, 12,687 against).

FOR 99.9%

FOR: 42,917,359 (99.9%)AGAINST: 12,687 (0.0%)ABSTAIN: 24,919 (0.1%)NOT VOTED: 76 (0.0%)

Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting ” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,706,690	5,541	0	For
BlackRock	5,655,112	0	0	For
T. Rowe Price	3,708,593	0	0	For
Invesco	3,119,257	0	0	For
Capitol Series Trust	2,129,381	0	0	For
Fidelity	1,947,252	0	0	For
Thrivent	733,486	0	0	For
State Street	715,181	42	0	For
Charles Schwab	687,587	0	0	For
CARILLON SERIES TRUST	639,325	0	0	For
JPMorgan	611,921	0	0	For
Jackson National	569,682	0	0	For
Capital Group	496,056	0	0	For
American Century	493,733	0	0	For
Dimensional	491,921	0	0	For
Columbia Threadneedle	484,200	0	0	For
Prudential/PGIM	473,875	0	0	For
Putnam	456,707	0	0	For
AllianceBernstein	390,698	0	0	For
SEI	327,442	0	0	For
Goldman Sachs	287,835	0	0	For
ETF Series Solutions	262,678	0	0	For
OBERWEIS FUNDS	243,500	0	0	For
TIAA	243,138	0	0	For
Brighthouse	209,233	0	24,919	For

Showing the 25 largest of 145 asset managers. See all 145 in the interactive database.

13. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

97% Majority: yes · of votes cast

FOR 97%

FOR: 83,410,829AGAINST: 3,006,776

The 26 asset managers below cast 89% of the shares they voted on this item FOR (642,660 for, 81,512 against).

FOR 89%11%

FOR: 642,660 (88.5%)AGAINST: 81,512 (11.2%)ABSTAIN: 1,780 (0.2%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Lightrock Netherlands B.V.	146,606	0	0	For
Empower	131,371	0	0	For
Eversept Partners, LP	123,599	0	0	For
NORDEA INVESTMENT MANAGEMENT AB	84,719	0	0	For
Brighthouse	65,261	0	0	For
Union Investment Management GmbH	0	40,309	0	Against
Wilshire Advisors LLC	28,847	0	0	For
Cardano Risk Management B.V.	0	20,796	0	Against
APG Asset Management US Inc.	0	20,407	0	Against
Lincoln Financial	17,560	0	0	For
ADVISORY RESEARCH INC	14,451	0	0	For
BlackRock	8,767	0	0	For
Select Asset Management & Trust	7,387	0	0	For
GLOBEFLEX CAPITAL L P	6,027	0	0	For
WASHINGTON CAPITAL MANAGEMENT, INC	3,350	0	0	For
ALGERT GLOBAL LLC	0	0	1,780	Abstain
Integrated Quantitative Investments LLC	1,500	0	0	For
WHITENER CAPITAL MANAGEMENT, INC.	1,000	0	0	For
Mowery & Schoenfeld Wealth Management, LLC	950	0	0	For
NORTHERN LIGHTS FUND TRUST II	600	0	0	For
Coyle Financial Counsel LLC	362	0	0	For
Convergence Investment Partners, LLC	193	0	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	63	0	0	For
Edgemoor Investment Advisors, Inc.	30	0	0	For
Synergy Investment Management, LLC	15	0	0	For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

14. Say on Pay

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,037 for, 0 against).

FOR: 1,037 (100.0%)

Largest asset managers voting on “Say on Pay” at Encompass Health Corporation, 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Arista Wealth Management, LLC	615	0	0	0	For
Empower	422	0	0	0	For

Largest Encompass Health Corporation shareholders voting in 2025-2026

Ranked by the number of Encompass Health Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 99,199,080 shares outstanding at the time of that meeting.

Top Encompass Health Corporation shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	12.60%
2	T. Rowe Price	11.42%
3	BlackRock	9.75%
4	Invesco	7.03%
5	Wellington	3.28%
6	State Street	2.83%
7	AllianceBernstein	2.58%
8	Fidelity	2.27%
9	FULLER & THALER ASSET MANAGEMENT, INC.	2.24%
10	Capitol Series Trust	2.15%

Reported Encompass Health Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Encompass Health Corporation beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	10.86%	13F
The Vanguard Group	10.20%	DEF14A
T. Rowe Price	4.64%	13F
Wellington Management	3.88%	13F
Invesco	3.41%	13F
State Street	3.17%	13F
Two Sigma	2.24%	13F
Geode Capital	1.91%	13F
Goldman Sachs	1.82%	13F
Dimensional Fund Advisors	1.69%	13F

Percentages above are of 99,199,080 shares outstanding, as reported by Encompass Health Corporation on its Form 10-Q dated 2026-04-24 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Encompass Health Corporation’s 10-Q dated 2026-04-24. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Encompass Health Corporation's shareholder meeting held 2026-05-07, in the 2025-2026 proxy season, 597 asset managers reported how they voted in their SEC Form N-PX filings, covering 8,111 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory vote to approve executive compensation. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Encompass Health Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-11.

Encompass Health Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).